全文获取类型
收费全文 | 1337篇 |
免费 | 81篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 70篇 |
妇产科学 | 16篇 |
基础医学 | 195篇 |
口腔科学 | 27篇 |
临床医学 | 105篇 |
内科学 | 346篇 |
皮肤病学 | 40篇 |
神经病学 | 42篇 |
特种医学 | 90篇 |
外科学 | 92篇 |
综合类 | 66篇 |
一般理论 | 1篇 |
预防医学 | 80篇 |
眼科学 | 27篇 |
药学 | 134篇 |
中国医学 | 16篇 |
肿瘤学 | 85篇 |
出版年
2023年 | 9篇 |
2022年 | 10篇 |
2021年 | 28篇 |
2020年 | 27篇 |
2019年 | 18篇 |
2018年 | 24篇 |
2017年 | 13篇 |
2016年 | 23篇 |
2015年 | 27篇 |
2014年 | 37篇 |
2013年 | 47篇 |
2012年 | 68篇 |
2011年 | 63篇 |
2010年 | 57篇 |
2009年 | 34篇 |
2008年 | 53篇 |
2007年 | 43篇 |
2006年 | 46篇 |
2005年 | 34篇 |
2004年 | 21篇 |
2003年 | 33篇 |
2002年 | 35篇 |
2001年 | 32篇 |
2000年 | 23篇 |
1999年 | 35篇 |
1998年 | 33篇 |
1997年 | 20篇 |
1996年 | 24篇 |
1995年 | 16篇 |
1994年 | 16篇 |
1993年 | 12篇 |
1992年 | 37篇 |
1991年 | 33篇 |
1990年 | 25篇 |
1989年 | 51篇 |
1988年 | 42篇 |
1987年 | 33篇 |
1986年 | 28篇 |
1985年 | 29篇 |
1984年 | 21篇 |
1983年 | 14篇 |
1982年 | 11篇 |
1980年 | 8篇 |
1979年 | 18篇 |
1978年 | 13篇 |
1977年 | 12篇 |
1976年 | 12篇 |
1975年 | 17篇 |
1973年 | 8篇 |
1972年 | 8篇 |
排序方式: 共有1436条查询结果,搜索用时 484 毫秒
141.
Kinetics of lymphocyte subpopulation in intestinal mucosa of protein deficient Giardia lamblia infected mice. 下载免费PDF全文
Kinetics of gut lymphocyte subpopulations were studied in normal and malnourished groups of mice infected with Giardia lamblia. The maximum parasite load was observed at second, third, and first week of postinfection in normal controls, moderate (8%) and severe (3%) protein deficient groups respectively. The number of G lamblia trophozoite in 3% protein deficient group was low compared with control groups. A significant increase in T cell population of intraepithelial lymphocytes and lamina propria in normal and moderate protein deficient groups was observed with the development of infection. It was less marked, however, in the severely malnourished group. Interplay of mucosal immune status with nutrition and G lamblia infection is discussed. 相似文献
142.
In silico analyses of missense mutations in coagulation factor VIII: identification of severity determinants of haemophilia A 下载免费PDF全文
Factor VIII (FVIII) mutations cause haemophilia A (HA), an X‐linked recessive coagulation disorder. Over 1000 missense mutations in FVIII are known and they lead to variable clinical phenotypes (severe, moderate and mild). The exact molecular basis of this phenotypic heterogeneity by FVIII missense mutations is elusive to date. In this study, we aimed to identify the severity determinants that cause phenotypic heterogeneity of HA. We compiled and curated a data set of 766 missense mutations from the repertoire of missense mutations in FVIII. We analysed these mutations by computational programs (e.g. Swiss‐PdbViewer) and different mutation analysis servers (e.g. SIFT, PROVEAN, CUPSAT, PolyPhen2, MutPred); and various sequence‐ and structure‐based parameters were assessed for any significant distribution bias among different HA phenotypes. Our analyses suggest that ‘mutations in evolutionary conserved residues’, ‘mutations in buried residues’, mutation‐induced ‘steric clash’ and ‘surface electrostatic potential alteration’ act as risk factors towards severe HA. We have developed a grading system for FVIII mutations combining the severity determinants, and the grading pattern correlates with HA phenotype. This study will help to correctly associate the HA phenotype with a mutation and aid early characterization of novel variants. 相似文献
143.
144.
145.
Salvador Alonso Meng Su Jace W. Jones Sudipto Ganguly Maureen A. Kane Richard J. Jones Gabriel Ghiaur 《Oncotarget》2015,6(17):14905-14912
Substantial evidence now demonstrates that interactions between the tumor microenvironment and malignant cells are a critical component of clinical drug resistance. However, the mechanisms responsible for microenvironment-mediated chemoprotection remain unclear. We showed that bone marrow (BM) stromal cytochrome P450 (CYP)26 enzymes protect normal hematopoietic stem cells (HSCs) from the pro-differentiation effects of retinoic acid. Here, we investigated if stromal expression of CYPs is a general mechanism of chemoprotection. We found that similar to human hepatocytes, human BM-derived stromal cells expressed a variety of drug-metabolizing enzymes. CYP3A4, the liver''s major drug-metabolizing enzyme, was at least partially responsible for BM stroma''s ability to protect multiple myeloma (MM) and leukemia cells from bortezomib and etoposide, respectively, both in vitro and in vivo. Moreover, clarithromycin overcame stromal-mediated MM resistance to dexamethasone, suggesting that CYP3A4 inhibition plays a role in its ability to augment the activity of lenalidomide and dexamethasone as part of the BiRd regimen. We uncovered a novel mechanism of microenvironment-mediated drug resistance, whereby the BM niche creates a sanctuary site from drugs. Targeting these sanctuaries holds promise for eliminating minimal residual tumor and improving cancer outcomes. 相似文献
146.
Marco Trerotola Kirat K. Ganguly Ladan Fazli Carmine Fedele Huimin Lu Anindita Dutta Qin Liu Tiziana De Angelis Luke W. Riddell Natalia A. Riobo Martin E. Gleave Amina Zoubeidi Richard G. Pestell Dario C. Altieri Lucia R. Languino 《Oncotarget》2015,6(16):14318-14328
In this study, we show that the transmembrane glycoprotein Trop-2 is up-regulated in human prostate cancer (PCa) with extracapsular extension (stages pT3/pT4) as compared to organ-confined (stage pT2) PCa. Consistent with this evidence, Trop-2 expression is found to be increased in metastatic prostate tumors of Transgenic Adenocarcinoma of Mouse Prostate mice and to strongly correlate with α5β1 integrin levels. Using PCa cells, we show that Trop-2 specifically associates with the α5 integrin subunit, as binding to α3 is not observed, and that Trop-2 displaces focal adhesion kinase from focal contacts. In support of the role of Trop-2 as a promoter of PCa metastatic phenotype, we observe high expression of this molecule in exosomes purified from Trop-2-positive PCa cells. These vesicles are then found to promote migration of Trop-2-negative PCa cells on fibronectin, an α5β1 integrin/focal adhesion kinase substrate, thus suggesting that the biological function of Trop-2 may be propagated to recipient cells. In summary, our findings show that Trop-2 promotes an α5β1 integrin-dependent pro-metastatic signaling pathway in PCa cells and that the altered expression of Trop-2 may be utilized for early identification of capsule-invading PCa. 相似文献
147.
Siddhartha Ganguly Trisha Home Abdulraheem Yacoub Suman Kambhampati Huidong Shi Prasad Dandawate Subhash Padhye Ashok K. Saluja Joseph McGuirk Rekha Rao 《Oncotarget》2015,6(31):31767-31779
CLL is a disease characterized by chromosomal deletions, acquired copy number changes and aneuploidy. Recent studies have shown that overexpression of Heat Shock Factor (HSF) 1 in aneuploid tumor cells can overcome deficiencies in heat shock protein (HSP) 90-mediated protein folding and restore protein homeostasis. Interestingly, several independent studies have demonstrated that HSF1 expression and activity also affects the chaperoning of HSP90 kinase clients, although the mechanism underlying this observation is unclear. Here, we determined how HSF1 regulates HSP90 function using CLL as a model system. We report that HSF1 is overexpressed in CLL and treatment with triptolide (a small molecule inhibitor of HSF1) induces apoptosis in cultured and primary CLL B-cells. We demonstrate that knockdown of HSF1 or its inhibition with triptolide results in the reduced association of HSP90 with its kinase co-chaperone cell division cycle 37 (CDC37), leading to the partial depletion of HSP90 client kinases, Bruton''s Tyrosine Kinase (BTK), c-RAF and cyclin-dependent kinase 4 (CDK4). Treatment with triptolide or HSF1 knockdown disrupts the cytosolic complex between HSF1, p97, HSP90 and the HSP90 deacetylase- Histone deacetylase 6 (HDAC6). Consequently, HSF1 inhibition results in HSP90 acetylation and abrogation of its chaperone function. Finally, tail vein injection of Mec-1 cells into Rag2−/−IL2Rγc−/− mice followed by treatment with minnelide (a pro-drug of triptolide), reduced leukemia, increased survival and attenuated HSP90-dependent survival signaling in vivo. In conclusion, our study provides a strong rationale to target HSF1 and test the activity of minnelide against human CLL. 相似文献
148.
149.
150.